Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Completed · Phase 2 · Has a placebo group

Conditions studied: Painful Lumbosacral Radiculopathy

In brief

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Key facts

Study ID
NCT06176196
Run by
Vertex Pharmaceuticals Incorporated
People needed
218
Starts
2023-12-13
Expected to finish
2024-10-16
Last updated by the study team
2025-10-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.